María Esther Sánchez Sánchez-rekin lankidetzan egindako argitalpenak (7)

2014

  1. Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration

    International Journal of Pharmaceutics, Vol. 477, Núm. 1, pp. 32-38

1992

  1. Effect of humidity and packaging on the long-term aging of commercial sustained-release theophylline tablets

    International Journal of Pharmaceutics, Vol. 83, Núm. 1-3, pp. 59-63

1990

  1. A new approach to pharmacokinetic parameters: Estimation of cefuroxime during haemodialysis

    Biopharmaceutics & Drug Disposition, Vol. 11, Núm. 2, pp. 107-120

  2. Discrepancy between pharmacopoeial dissolution tests and bioavailability of pharmacetamol tablets

    Farmaco, Vol. 45, Núm. 5, pp. 569-576

  3. Multivariate analysis of variance of dissolution data in the development of oral sustained release formulations

    Drug Development and Industrial Pharmacy, Vol. 16, Núm. 14, pp. 2145-2152

  4. Relationship between release and gastrointestinal absorption of theophylline

    Acta Pharmaceutica Technologica, Vol. 36, Núm. 1, pp. 7-10

1989

  1. Evaluation of HPLC methods for determination of theophylline in serum

    Revista de la Asociacion Espanola de Farmaceuticos de Hospitales, Vol. 13, Núm. 1, pp. 17-23